ArticleScience translational medicine2022
Risk assessment with gut microbiome and metabolite markers in NAFLD development.
Howell Leung et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
87 papers cite itlatest 60 shown
this paperpooled itcites it